Description: Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors.
Home Page: www.alphatau.com
DRTS Technical Analysis
5 Kiryat Hamada Street
Jerusalem,
9777605
Israel
Phone:
972 3 577 4115
Officers
| Name | Title |
|---|---|
| Mr. Uzi Sofer | CEO & Chairman |
| Mr. Raphi Levy | Chief Financial Officer |
| Mr. Amnon Gat | Chief Operations Officer |
| Mr. Ronen Segal | Chief Technology Officer |
| Prof. Yona Keisari | Chief Scientific Officer & Member of Scientific Advisory board |
| Ms. Rebecca Becker | VP of legal |
| Mr. Peter M. Melnyk | Chief Commercial Officer |
| Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board |
| Prof. Itzhak Kelson | Chief Physics Officer & Member of Scientific Advisory Board |
| Ms. Yael Zeiger | Corp. Controller |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.2584 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-03-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 83 |